Annual SG&A
$332.54 M
+$6.54 M+2.01%
31 December 2023
Summary:
PTC Therapeutics annual selling, general & administrative expenses is currently $332.54 million, with the most recent change of +$6.54 million (+2.01%) on 31 December 2023. During the last 3 years, it has risen by +$87.38 million (+35.64%). PTCT annual SG&A is now at all-time high.PTCT Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$73.46 M
+$3.96 M+5.69%
30 September 2024
Summary:
PTC Therapeutics quarterly selling, general & administrative expenses is currently $73.46 million, with the most recent change of +$3.96 million (+5.69%) on 30 September 2024. Over the past year, it has dropped by -$7.43 million (-9.19%). PTCT quarterly SG&A is now -20.77% below its all-time high of $92.72 million, reached on 31 December 2022.PTCT Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$13.71 B
-$453.20 M-3.42%
30 September 2024
Summary:
PTC Therapeutics TTM selling, general & administrative expenses is currently -$13.71 billion, with the most recent change of -$453.20 million (-3.42%) on 30 September 2024. Over the past year, it has dropped by -$14.06 billion (-4029.90%). PTCT TTM SG&A is now -4846.91% below its all-time high of $348.97 million, reached on 30 September 2023.PTCT TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTCT Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.0% | -9.2% | -4029.9% |
| 3 y3 years | +35.6% | +6.1% | -5092.7% |
| 5 y5 years | +116.6% | +49.0% | -7406.0% |
PTCT Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +35.6% | -20.8% | +6.1% | -93.0% | at low |
| 5 y | 5 years | at high | +116.6% | -20.8% | +49.0% | -233.2% | at low |
| alltime | all time | at high | +2175.3% | -20.8% | +2221.3% | -4846.9% | at low |
PTC Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $73.46 M(+5.7%) | $292.52 M(-2.5%) |
| June 2024 | - | $69.50 M(-5.1%) | $299.95 M(-5.9%) |
| Mar 2024 | - | $73.27 M(-4.0%) | $318.90 M(-4.1%) |
| Dec 2023 | $332.54 M(+2.0%) | $76.29 M(-5.7%) | $332.54 M(-4.7%) |
| Sept 2023 | - | $80.89 M(-8.6%) | $348.97 M(+0.2%) |
| June 2023 | - | $88.45 M(+1.8%) | $348.20 M(+2.5%) |
| Mar 2023 | - | $86.91 M(-6.3%) | $339.64 M(+4.2%) |
| Dec 2022 | $326.00 M(+14.1%) | $92.72 M(+15.7%) | $326.00 M(+1.9%) |
| Sept 2022 | - | $80.12 M(+0.3%) | $319.83 M(+3.5%) |
| June 2022 | - | $79.89 M(+9.0%) | $308.96 M(+3.7%) |
| Mar 2022 | - | $73.27 M(-15.3%) | $297.95 M(+4.3%) |
| Dec 2021 | $285.77 M(+16.6%) | $86.55 M(+25.0%) | $285.77 M(+4.0%) |
| Sept 2021 | - | $69.25 M(+0.5%) | $274.68 M(+4.3%) |
| June 2021 | - | $68.88 M(+12.7%) | $263.27 M(+6.1%) |
| Mar 2021 | - | $61.09 M(-19.0%) | $248.05 M(+1.2%) |
| Dec 2020 | $245.16 M(+21.0%) | $75.46 M(+30.5%) | $245.16 M(+5.1%) |
| Sept 2020 | - | $57.84 M(+7.8%) | $233.21 M(+3.8%) |
| June 2020 | - | $53.66 M(-7.8%) | $224.65 M(+2.0%) |
| Mar 2020 | - | $58.21 M(-8.3%) | $220.21 M(+8.7%) |
| Dec 2019 | $202.54 M(+31.9%) | $63.50 M(+28.8%) | $202.54 M(+7.9%) |
| Sept 2019 | - | $49.28 M(+0.1%) | $187.71 M(+6.2%) |
| June 2019 | - | $49.22 M(+21.4%) | $176.79 M(+9.7%) |
| Mar 2019 | - | $40.54 M(-16.7%) | $161.12 M(+4.9%) |
| Dec 2018 | $153.55 M | $48.67 M(+26.8%) | $153.55 M(+9.4%) |
| Sept 2018 | - | $38.37 M(+14.4%) | $140.37 M(+5.2%) |
| June 2018 | - | $33.55 M(+1.7%) | $133.42 M(+3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $32.97 M(-7.1%) | $128.74 M(+6.2%) |
| Dec 2017 | $121.27 M(+24.9%) | $35.48 M(+12.9%) | $121.27 M(+10.3%) |
| Sept 2017 | - | $31.42 M(+8.9%) | $109.96 M(+7.6%) |
| June 2017 | - | $28.87 M(+13.2%) | $102.19 M(+5.7%) |
| Mar 2017 | - | $25.50 M(+5.5%) | $96.69 M(-0.5%) |
| Dec 2016 | $97.13 M(+18.3%) | $24.17 M(+2.2%) | $97.13 M(-1.7%) |
| Sept 2016 | - | $23.65 M(+1.2%) | $98.84 M(+2.4%) |
| June 2016 | - | $23.37 M(-9.9%) | $96.56 M(+6.8%) |
| Mar 2016 | - | $25.94 M(+0.2%) | $90.40 M(+10.1%) |
| Dec 2015 | $82.08 M(+83.1%) | $25.89 M(+21.1%) | $82.08 M(+10.6%) |
| Sept 2015 | - | $21.37 M(+24.2%) | $74.21 M(+17.1%) |
| June 2015 | - | $17.21 M(-2.3%) | $63.37 M(+15.4%) |
| Mar 2015 | - | $17.61 M(-2.2%) | $54.90 M(+22.5%) |
| Dec 2014 | $44.82 M(+77.7%) | $18.02 M(+71.1%) | $44.82 M(+30.7%) |
| Sept 2014 | - | $10.53 M(+20.6%) | $34.29 M(+12.7%) |
| June 2014 | - | $8.73 M(+15.8%) | $30.44 M(+7.6%) |
| Mar 2014 | - | $7.54 M(+0.7%) | $28.30 M(+12.2%) |
| Dec 2013 | $25.22 M(+72.6%) | $7.48 M(+12.1%) | $25.22 M(+20.3%) |
| Sept 2013 | - | $6.68 M(+1.3%) | $20.96 M(+16.0%) |
| June 2013 | - | $6.59 M(+47.8%) | $18.06 M(+23.4%) |
| Mar 2013 | - | $4.46 M(+38.4%) | $14.63 M(+0.1%) |
| Dec 2012 | $14.62 M(-9.5%) | $3.22 M(-14.8%) | $14.62 M(+28.3%) |
| Sept 2012 | - | $3.78 M(+19.6%) | $11.39 M(+49.7%) |
| June 2012 | - | $3.16 M(-28.8%) | $7.61 M(+71.2%) |
| Mar 2012 | - | $4.44 M | $4.44 M |
| Dec 2011 | $16.15 M | - | - |
FAQ
- What is PTC Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for PTC Therapeutics?
- What is PTC Therapeutics annual SG&A year-on-year change?
- What is PTC Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for PTC Therapeutics?
- What is PTC Therapeutics quarterly SG&A year-on-year change?
- What is PTC Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for PTC Therapeutics?
- What is PTC Therapeutics TTM SG&A year-on-year change?
What is PTC Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of PTCT is $332.54 M
What is the all time high annual SG&A for PTC Therapeutics?
PTC Therapeutics all-time high annual selling, general & administrative expenses is $332.54 M
What is PTC Therapeutics annual SG&A year-on-year change?
Over the past year, PTCT annual selling, general & administrative expenses has changed by +$6.54 M (+2.01%)
What is PTC Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of PTCT is $73.46 M
What is the all time high quarterly SG&A for PTC Therapeutics?
PTC Therapeutics all-time high quarterly selling, general & administrative expenses is $92.72 M
What is PTC Therapeutics quarterly SG&A year-on-year change?
Over the past year, PTCT quarterly selling, general & administrative expenses has changed by -$7.43 M (-9.19%)
What is PTC Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of PTCT is -$13.71 B
What is the all time high TTM SG&A for PTC Therapeutics?
PTC Therapeutics all-time high TTM selling, general & administrative expenses is $348.97 M
What is PTC Therapeutics TTM SG&A year-on-year change?
Over the past year, PTCT TTM selling, general & administrative expenses has changed by -$14.06 B (-4029.90%)